Development of experimental alloxan model of diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 4
Abstract
Background. One of the main causes that lead to the disability of diabetic patients is diabetic retinopathy (DR). The relevance of the problem of DR necessitates the development of optimal experimental models on experimental animals to find effective ways of correcting this pathology. The purpose of our work was to develop an experimental alloxan model of type 1 diabetes mellitus (DM) for the study of DR, which would not result in the lethal outcome of experimental animals under the action of alloxan; histological examination of changes in the tissues of the eyeball in the reproduction of the DM model for the selection of new effective methods for the metabolic treatment of DR in the early stages. Materials and methods. The experiment was carried out on white outbred Wistar rats weighing 180–200 g. The first group consisted of 20 animals that were not subjected to any influence, served as a control; second group — 30 animals, in which DM was modeled by administration of alloxan and fructose. Results. When modeling DR, vessel changes in the form of wall fibrosis, edema of the endothelium and vasospasm were found. There was also a decrease in the amount of pigment granules, dystrophic changes in the cells of the ganglionic layer and a layer of retinal rods and cones, which coincides with the descriptions of damage to the coats of the eyeball in patients with DM. Conclusions. In our studies, we have calculated the optimal dose of alloxan administration, which does not lead to the death of rats (the lethality of rats was absent) and is an effective model not only of DM in general, but also of DR.
Authors and Affiliations
V. V. Semenko, V. M. Serdyuk, I. V. Savytskyi
Keywords
Related Articles
- EP ID EP213095
- DOI 10.22141/2224-0721.13.4.2017.106657
- Views 84
- Downloads 0
Clinical Case of Newly Diagnosed Hypoglycemic Paroxysm Complicated by Severe Neurological Disorders
The paper presents a case of hypoglycemic paroxysm, manifested as epilepsy, in 53-year-old man, suffering from diabetes mellitus type 1, complicated by steatohepatosis following excretory and endocrine pancreatic insuffi...
A Case of Pituitary Hypoplasia Combined with Achondroplasia in Six-Year-Old Boy
A case of achondroplasia combined with pituitary hypoplasia in 6-year-old boy is described. It is recommended to carry out magnetic resonance imaging of hypophysis in patients with achondroplasia to identify its possible...
Associations between Mycoplasma and Components of Immune Response in Women with Autoimmune Thyroiditis
There was investigated immunoglobulin G (IgG) to the mycoplasma (Mp) in the blood serum of women with autoimmune thyroiditis (AIT) of reproductive age and in postmenopausal periods. A control group consisted of women of...
What was Known about Diabetes Mellitus in Ancient Times? (to Help Teachers and Students of Schools of Diabetes)
.
Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine)
The paper describes the efficacy of sulfonylurea derivative — domestic medication Dіaglizide MR (Farmak, Ltd) in the treatment of type 2 diabetes mellitus. The efficacy and safety of the agent confirmed in scientific stu...